Geneoscopy Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 54

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $105M

  • Investors
  • 17

Geneoscopy General Information

Description

Developer of a diagnostics technology designed to treat digestive diseases and also offer cancer screening services. The company's technology consistently extracts stool-derived eukaryotic RNA (seRNA) transcripts and detects changes in gene expression, enabling doctors to better prevent, detect and guide treatment for gastrointestinal disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 2220 Welsch Industrial Court
  • Saint Louis, MO 63146
  • United States

Geneoscopy Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Geneoscopy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 16-Nov-2021 $105M 00000 00000 Completed Generating Revenue
8. Later Stage VC 01-Jan-2021 00.000 Completed Generating Revenue
7. Debt - PPP 08-Apr-2020 00.000 Completed Generating Revenue
6. Early Stage VC (Series A) 18-Sep-2019 00.000 00.000 000.00 Completed Generating Revenue
5. Grant 15-Nov-2016 0000 00000 Completed Startup
4. Grant 01-Jan-2016 0000 00000 Completed Startup
3. Accelerator/Incubator 00000 00000 Completed Startup
2. Accelerator/Incubator $22.6K Completed Startup
1. Capitalization 01-Jan-2015 $22.6K $22.6K Completed Startup
To view Geneoscopy’s complete valuation and funding history, request access »

Geneoscopy Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 000,000 00.000000 000.00 000.00 00 000.00 0.000
Series B 0,000,000 00.000000 000.00 000.00 00 000.00 00.000
Series A-1 239,352 $0.000100 $4.27 $4.27 1x $4.27 6.3%
Series A 973,898 $0.000100 $7.4 $7.4 1x $7.4 25.64%
To view Geneoscopy’s complete cap table history, request access »

Geneoscopy Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostics technology designed to treat digestive diseases and also offer cancer screening services. The
Diagnostic Equipment
Saint Louis, MO
54 As of 2022
00000
0000 0000-00-00
00000000000 00000

000000

ore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco lab
0000000000 000000000
Bridgewater, NJ
00 As of 0000
0000
00000000000 0000

000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000 000000000
Beverly, MA
00 As of 0000
00.00
0000000000 0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Geneoscopy Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clinical Genomics Venture Capital-Backed Bridgewater, NJ 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Beverly, MA 00 00.00 0000000000 0 00.00
0000000 Venture Capital-Backed Irvine, CA 000 00000 00000000
00000 00000000 Formerly VC-backed Madison, WI 0000 00.000 00000000 00.000
0000000000 0000000 Formerly VC-backed Cambridge, MA 0000 00000 00000000000
You’re viewing 5 of 20 competitors. Get the full list »

Geneoscopy Patents

Geneoscopy Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019276577-A1 Detection method Pending 01-Jun-2018 0000000000
CA-3136405-A1 Detection method Pending 01-Jun-2018 0000000000
EP-3802885-A4 Detection method Pending 01-Jun-2018 0000000000
EP-3802885-A1 Detection method Pending 01-Jun-2018 0000000000
US-20210214797-A1 Detection method Pending 01-Jun-2018 C12Q1/6886
To view Geneoscopy’s complete patent history, request access »

Geneoscopy Executive Team (8)

Name Title Board Seat Contact Info
Andrew Barnell Co-Founder, Chief Executive Officer, Chief Finance Officer & Board Member
Yiming Kang Ph.D Co-Founder & Chief Technology Officer
Erica Barnell Ph.D Co-Founder & Chief Science Officer
Vince Wong Chief Commercial Officer
Jake Miller Head of Finance
You’re viewing 5 of 8 executive team members. Get the full list »

Geneoscopy Board Members (6)

Name Representing Role Since
Andrew Barnell Geneoscopy Co-Founder, Chief Executive Officer, Chief Finance Officer & Board Member 000 0000
Bobby Sandage Ph.D Cultivation Capital Board Member 000 0000
Drew Dennison Self Board Member 000 0000
James Merselis Self Board Member 000 0000
Mark Zorensky Self Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Geneoscopy Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Geneoscopy Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioGenerator Venture Capital Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
LabCorp Ventures Corporate Venture Capital Minority 000 0000 000000 0
Morningside Group Venture Capital Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »